How big data is benefitting asthma devices

Pharmaceutical companies are set to benefit from intelligence on asthma as Aerobit, provider of a smart respiratory device, teams with artificial intelligence experts to unlock the potential of big data. To more effectively manage asthma care, Aerobit has introduced a smart inhaler which tracks medication use and records each time an inhaler is taken by an asthma patient. Patients receive reminders and alerts for their prescribed medical regime. Doctors are able to track treatment progress and compliance. In recognising the value of big data, Aerobit has teamed with artificial intelligence experts Eularis, to enable pharmaceutical companies to gain a deeper understanding of patient needs, drug efficacy and adherence, and real world data to drive accelerated growth for asthma drugs.